Related Experiment Video
Updated: Jun 3, 2026

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
Does dementia increase risk of thrombolysis?: a case-control study
A Alshekhlee1, C-C Li, S-Y Chuang
1Souers Stroke Institute, Department of Neurology and Psychiatry, St. Louis University, 1438 S. Grand Blvd., St. Louis, MO 63104, USA. aalshekh@slu.edu
Thrombolysis for acute ischemic stroke in dementia patients did not increase risks of intracerebral hemorrhage or death compared to those without dementia. Intracerebral hemorrhage remained a predictor of mortality in both groups.
Area of Science:
- Neurology
- Geriatrics
- Internal Medicine
Background:
- Dementia poses challenges for thrombolysis in acute ischemic stroke (AIS).
- Assessing the impact of dementia on outcomes after thrombolysis is crucial.
Purpose of the Study:
- To evaluate the effect of dementia on intracerebral hemorrhage (ICH) and hospital mortality rates in AIS patients treated with thrombolysis.
- To compare outcomes of thrombolysis in AIS patients with and without dementia.
Main Methods:
- Utilized the National Inpatient Sample database (2000-2007) for patients with AIS.
- Identified dementia using ICD-9-CM codes and selected matched controls without dementia treated with thrombolysis.
Main Results:
- Among 35,557 dementia patients, 207 received thrombolysis.
- Thrombolysis in dementia patients showed similar ICH (5.80% vs 4.51%) and mortality (17.39% vs 14.49%) rates compared to matched non-dementia controls.
- Intracerebral hemorrhage was a significant predictor of mortality in both groups.
Conclusions:
- Thrombolysis for AIS in patients with dementia is not associated with increased ICH or mortality risk compared to non-dementia patients.
- Intracerebral hemorrhage remains a key predictor of mortality following thrombolysis, irrespective of dementia status.
Related Concept Videos
Dementia l: Introduction
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Dementia
The progression of dementia is generally gradual.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemorrhagic Stroke ll: Pathophysiology
